|
Ultimately, moving on without Walgreen is not the preferred approach for Express Scripts, said Dave Shove, a BMO Capital markets analyst who covers the company. He noted that CVS Caremark Corp. has gained Walgreen customers since the split. CVS operates both drugstores and a PBM business. Shove said a larger CVS will be harder for Express Scripts to negotiate with in the future. "Express, we believe, needs both large chains in their network in order to keep a balance, get more competitive rates," he said. Express Scripts released its prescription totals as part of a broader first-quarter earnings report distributed Thursday after markets closed. Overall, company earnings fell 18 percent compared to last year's first quarter. It earned $267.8 million, or 55 cents per share, in the first three months of 2012, as revenue climbed 9 percent to $12.13 billion. Express Scripts said costs tied to the Medco deal affected its performance. Adjusted earnings, which exclude those costs and other items, were 73 cents per share. That fell short of analyst expectations of 77 cents per share.
Express Scripts shares climbed 2.6 percent, or $1.40, to $55.74 in afternoon trading, while the Nasdaq exchange rose less than 1 percent.
[Associated
Press;
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor